Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104230880A enables cost-effective Atorvastatin side chain production. Reliable supplier for pharmaceutical intermediates with scalable green chemistry.
Patent CN109053387B details a novel two-step Magnolol synthesis using NbCl5 catalysis. This route offers mild conditions, high selectivity, and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Novel Lewis acid catalyzed route for 3-(4-methoxyphenyl)succinimide. High yield, reduced waste, scalable for pharmaceutical intermediate supply chains.
Advanced synthesis of Remdesivir intermediates via optimized cyanation and ammonolysis. Reduces waste and improves scalability for pharmaceutical manufacturing.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110606805A reveals a dual-synthesis route offering high purity and environmental compliance for global supply chains. This method ensures reliable availability of critical fine chemical intermediates for pharmaceutical applications.
Novel FeCl3-catalyzed route for polysubstituted N-arylpyrroles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for scalable production.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN108530381B details a solvent-free method for diamine synthesis using saccharin. This offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105777486B details a novel synthetic route for posaconazole intermediates offering reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN115197139A reveals a green, high-yield route for Roxadustat intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN111484397B details a novel FeCl3 or I2 catalyzed one-pot synthesis for triarylmethane derivatives, enabling cost-effective manufacturing and reliable supply chain solutions.
Patent CN119241513B reveals green synthesis for antibacterial intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel 3-step synthesis for Dapagliflozin ensures high yield and purity. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Patent CN104860897A reveals a novel Lewis acid catalyzed route for Hepatitis C intermediates. Achieve superior chiral purity and supply chain reliability with scalable manufacturing.
Patent CN102503887B reveals a mild AgOTf-catalyzed route to isoquinolines. This method offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel Lewis acid catalyzed synthesis reduces reaction time significantly. High yield pharmaceutical intermediate production with scalable supply chain reliability for global partners.
Patent CN1775764A details a high-yield tetrazole synthesis using Yb(OTf)3. This method offers significant cost reduction in API manufacturing and improved supply chain reliability.